NY S09890

Directs the opioid settlement fund advisory board to require the commissioner of health to conduct a study of 250 random urine samples collected anonymously from overdose patients across all New York counties.

Samples must be collected from emergency room patients experiencing moderate to severe opioid overdose symptoms, with written and verbal informed consent, and identified only by number to comply with HIPAA regulations.

Collected samples shall be analyzed at a designated laboratory using advanced chromatographic techniques (LC-MS-MS and GC-MS) to identify new opioid analogs, xylazine, and other unidentified opiate/opioid compounds or drug combinations.

Commissioner of health must compile study findings into a report due within one year, including recommended statewide emergency room treatment protocols that account for substances that may not respond to Narcan alone.

Report shall be submitted to the governor, legislature, and relevant committees, posted on the department of health website, and shared with hospitals and addiction treatment facilities; act expires 30 days after report delivery.